Courses

Diagnostic & Therapeutic Advances in Eosinophilic Esophagitis

Program Date: 06 September 2019

Publication Date: 15 January 2020

Continuing Education Credits: Nurse Contact 1.0 CE; Dietitian 1.0 CPEU

Course Description

In this course, Evan S. Dellon, MD, MPH, will discuss diagnostic advances, including the new international consensus diagnostic guidelines; discuss the rationale and approach to dietary elimination therapy, less restrictive strategies for dietary elimination, and novel approaches to identifying dietary triggers; review pharmacologic treatments for EoE; and more! Originally presented at the Eosinophilic Oesophagitis Symposium on 07 September 2019, in Australia.

Course Objectives
  • Discuss diagnostic advances, including the new international consensus diagnostic guidelines. 
  • Discuss the rationale and approach to dietary elimination therapy, less restrictive strategies for dietary elimination, and novel approaches to identifying dietary triggers.
  • Provide an overview of pharmacologic treatments for EoE. 
  • Present an overall treatment algorithm for EoE.

Performance Indicators: 5.2.7, 9.1.1, 11.3.4

Activity Code: 185059

Course Instructor Bio(s)

Evan S. Dellon, MD, MPH

Professor, Medicine and Epidemiology 
Center for Esophageal Diseases and Swallowing
University of North Carolina School of Medicine
Chapel Hill, NC, USA

Evan S. Dellon, MD, MPH, is a Professor of Medicine and Adjunct Associate Professor of Epidemiology at the University of North Carolina School of Medicine in Chapel Hill. Dr Dellon received his undergraduate degree from Brown University and his medical degree from Johns Hopkins School of Medicine. He completed an internship and residency in Internal Medicine at Massachusetts General Hospital. He performed a clinical and a research fellowship in Adult Gastroenterology at UNC, during which he also received a Master of Public Health degree in Epidemiology from the UNC School of Public Health. Dr Dellon joined the UNC faculty and the Center for Esophageal Diseases and Swallowing (CEDAS) in 2008, where his main clinical focus is on disorders of swallowing, and in particular eosinophilic esophagitis (EoE). He became Director of CEDAS in 2014 and is an Associate Editor for Clinical Gastroenterology and Hepatology.                         

Dr Dellon’s main research interest is in the epidemiology, pathogenesis, diagnosis, treatment, and outcomes of eosinophilic esophagitis (EoE) and eosinophilic GI diseases (EGIDs). The goal of his research is to improve the lives of patients with EoE and EGIDs by learning how to better diagnose, treat, and monitor the condition. He is widely published in this area and collaborates with investigators all over the world. Dr Dellon has received research funding from the National Institutes of Health, the American College of Gastroenterology, the American Gastroenterologic Association, the CURED Foundation, UNC, and several industry partners to study EoE and other EGIDs.

Category

Abbott Nutrition’s Provider Statement for Nursing CEs:

Abbott Nutrition Health Institute is an approved provider of continuing nursing education by the California Board of Registered Nursing Provider #CEP 11213.

Abbott Nutrition’s Statement for Dietitian CPEUs:

This educational activity has been prior-approved by the Commission on Dietetic Registration (CDR). CDR credentialed practitioners will receive the specified continuing professional education units (CPEUs) for completion of this program/material.